Correlation Between GlaxoSmithKline PLC and Santen Pharmaceutical
Can any of the company-specific risk be diversified away by investing in both GlaxoSmithKline PLC and Santen Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlaxoSmithKline PLC and Santen Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlaxoSmithKline PLC ADR and Santen Pharmaceutical Co, you can compare the effects of market volatilities on GlaxoSmithKline PLC and Santen Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlaxoSmithKline PLC with a short position of Santen Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlaxoSmithKline PLC and Santen Pharmaceutical.
Diversification Opportunities for GlaxoSmithKline PLC and Santen Pharmaceutical
0.33 | Correlation Coefficient |
Weak diversification
The 3 months correlation between GlaxoSmithKline and Santen is 0.33. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC ADR and Santen Pharmaceutical Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Santen Pharmaceutical and GlaxoSmithKline PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlaxoSmithKline PLC ADR are associated (or correlated) with Santen Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Santen Pharmaceutical has no effect on the direction of GlaxoSmithKline PLC i.e., GlaxoSmithKline PLC and Santen Pharmaceutical go up and down completely randomly.
Pair Corralation between GlaxoSmithKline PLC and Santen Pharmaceutical
Considering the 90-day investment horizon GlaxoSmithKline PLC ADR is expected to generate 0.55 times more return on investment than Santen Pharmaceutical. However, GlaxoSmithKline PLC ADR is 1.82 times less risky than Santen Pharmaceutical. It trades about -0.23 of its potential returns per unit of risk. Santen Pharmaceutical Co is currently generating about -0.3 per unit of risk. If you would invest 3,659 in GlaxoSmithKline PLC ADR on August 31, 2024 and sell it today you would lose (226.00) from holding GlaxoSmithKline PLC ADR or give up 6.18% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
GlaxoSmithKline PLC ADR vs. Santen Pharmaceutical Co
Performance |
| Timeline |
| GlaxoSmithKline PLC ADR |
| Santen Pharmaceutical |
GlaxoSmithKline PLC and Santen Pharmaceutical Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with GlaxoSmithKline PLC and Santen Pharmaceutical
The main advantage of trading using opposite GlaxoSmithKline PLC and Santen Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlaxoSmithKline PLC position performs unexpectedly, Santen Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Santen Pharmaceutical will offset losses from the drop in Santen Pharmaceutical's long position.| GlaxoSmithKline PLC vs. Novartis AG ADR | GlaxoSmithKline PLC vs. AstraZeneca PLC ADR | GlaxoSmithKline PLC vs. Roche Holding Ltd | GlaxoSmithKline PLC vs. Bristol Myers Squibb |
| Santen Pharmaceutical vs. Sanofi ADR | Santen Pharmaceutical vs. Bristol Myers Squibb | Santen Pharmaceutical vs. AstraZeneca PLC ADR | Santen Pharmaceutical vs. Gilead Sciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |